Diebold Nixdorf, Incorporated (DBD)
(Delayed Data from NYSE)
$41.00 USD
0.00 (0.00%)
Updated May 10, 2024 04:00 PM ET
After-Market: $40.98 -0.02 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
DBD 41.00 0.00(0.00%)
Will DBD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DBD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DBD
Are Computer and Technology Stocks Lagging Badger Meter (BMI) This Year?
What Makes Diebold Nixdorf, Incorporated (DBD) a Good Fit for 'Trend Investing'
DBD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Check Point (CHKP) Q1 Earnings & Sales Beat Expectations
SNAP Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Archrock and Diebold Nixdorf have been highlighted as Zacks Bull and Bear of the Day
Other News for DBD
Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
D.A. Davidson Keeps Their Buy Rating on Diebold Nixdorf Inc (DBD)
Wedbush upgrades Diebold with shares at '"extremely attractive levels'
Wedbush gets more bullish on Diebold, upgrades shares
Diebold Nixdorf Inc (DBD) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with ...